Wednesday, January 25, 2017

J&J to buy Actelion for $30 billion

ZURICH (Reuters) - Swiss biotech company Actelion said on Thursday it had agreed to be purchased by Johnson & Johnson in a $30 billion deal.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)